News

Ophthalmology Times20h
Positive topline results from phase 2 VVN461 trial for non-infectious anterior uveitis
VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, ...
Ophthalmology Advisor19h
Presbyopia Drop Improves Vision, Reading Speed With Low Risk of Side Effects
Investigators evaluated 12-month safety, efficacy of once-daily preservative-free carbachol 2.75%/brimonidine tartrate 0.1% ...